Last $0.0059 USD
Change Today -0.001 / -14.49%
Volume 419.3K
NPHC On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

nutra pharma corp (NPHC) Snapshot

Open
$0.0068
Previous Close
$0.0069
Day High
$0.0069
Day Low
$0.0055
52 Week High
06/23/14 - $0.02
52 Week Low
05/9/14 - $0.0030
Market Cap
8.3M
Average Volume 10 Days
1.4M
EPS TTM
$-0.0015
Shares Outstanding
1.4B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NUTRA PHARMA CORP (NPHC)

Related News

No related news articles were found.

nutra pharma corp (NPHC) Related Businessweek News

No Related Businessweek News Found

nutra pharma corp (NPHC) Details

Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, as well as homeopathic and ethical drugs for manages pain, neurological disorders, cancer, autoimmune, and infectious diseases. The company, through its subsidiary, ReceptoPharm, carries out homeopathic and drug discovery research and clinical development. It offers Cobroxin and Nyloxin/Nyloxin Extra Strength that are homeopathic over-the-counter drugs to treat moderate to severe chronic pain. The company is also developing RPI-78M to treat neurological diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, and myasthenia gravis; RPI-MN to treat viral diseases, such as HIV/AIDS and Herpes; RPI-78 for pain and arthritis; and RPI-70 for pain. In addition, it develops Pet Pain-Away, a homeopathic, non-narcotic, non-addictive, over-the-counter pain reliever to treat severe chronic pain in companion animals; and Equine Nyloxin, a topical therapy for horses. Nutra Pharma Corp. was founded in 2000 and is headquartered in Coral Springs, Florida.

3 Employees
Last Reported Date: 03/31/14
Founded in 2000

nutra pharma corp (NPHC) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $130.0K
Compensation as of Fiscal Year 2013.

nutra pharma corp (NPHC) Key Developments

Nutra Pharma Announces Manufacturing Release of Pet Pain Away and Delivery of Initial Orders

Nutra Pharma Corp. announced that they have received their first manufacturing run of their homeopathic treatment for chronic pain in companion animals, Pet Pain-Away™. The company also announced that they have begun shipping and many distributors have already received their first orders. Pet Pain-Away™ is a homeopathic, non-narcotic, non-addictive, over-the-counter pain reliever. The product is primarily aimed at treating moderate to severe chronic pain in companion animals. It is specifically indicated to treat pain from hip dysplasia, arthritis pain, joint pain, and general chronic pain in dogs, cats and horses. Specialized proteins in Pet Pain-Away block the action of acetylcholine, a major stimulating neurotransmitter in the nervous system and activator of the inflammatory pathways. As a result, the pain and inflammation pathways are temporarily shut off.

Nutra Pharma Announces Completion of Commercials by MyNyloxin.com

Nutra Pharma Corp. announced that MyNyloxin.com has the exclusive rights to market and distribute Nutra Pharma's over-the-counter (OTC) pain reliever, Nyloxin(R), in the Network Marketing channel, has completed their work on a series of commercials to start airing in the month of June 2014. The advertisements focus on the benefits of Nyloxin(R) and include 30 second, 60 second and 120 second spots.

Nutra Pharma Corporation announced delayed 10-Q filing

On 05/16/2014, Nutra Pharma Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NPHC:US $0.01 USD -0.001

NPHC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amgen Inc $163.46 USD +2.79
Bayer AG €114.86 EUR -0.61
Biogen Idec Inc $342.40 USD +1.51
Roche Holding AG SFr.270.10 CHF -3.20
View Industry Companies
 

Industry Analysis

NPHC

Industry Average

Valuation NPHC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 16.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 14.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NUTRA PHARMA CORP, please visit www.nutrapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.